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cascade leading to cell death are still unknown because of
the limitations of the existing methodology, strategy, and
modalities used. Methods: Imaging mass spectrometry
(IMS) was used to measure dynamic molecular changes of
phosphatidylcholine (PC) species in the rat hippocampus
after transient global ischemia (TGI) for 6 min. Fresh frozen
sections were obtained after euthanizing the rats on Days 1,
2, 4, 7, 10, 14, and 21. Histopathology and IMS of adjacent
sections compared morphological and molecular changes,
respectively. Results: Histopathological changes were
absent immediately after TGI (at Day 1, superacute phase).
At Days 2–21 after TGI (from subacute to chronic phases),
histopathology revealed neuronal death associated with
gliosis, inflammation, and accumulation of activated micro-
glia in CA1. IMS detected significant molecular changes
after TGI in the same CA1 domain: increase of PC (diacyl-
16:0/22:6) in the superacute phase and increase of PC
(diacyl-16:0/18:1) in the subacute to chronic phases. Con-
clusions: Histopathology and IMS can provide comprehen-
sive and complementary information on cell death
mechanisms in the hippocampal CA1 after global ischemia.
IMS provided novel data on molecular changes in phospho-
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INTRODUCTION
The brain is intrinsically more vulnerable to ischemia than
any other organ, and suﬀers signiﬁcant damage after only
a few minutes of cerebral blood ﬂow deprivation. The
actual mechanism causing damage to the brain,
particularly the neurons, still remains to be elucidated.
The hippocampus is recognized to be one of the most
vulnerable neuroanatomical regions to the eﬀects of
ischemia (Schmidt-Kastner and Freund, 1991; Blanco-
Suarez et al., 2014). Consequently, transient global ische-
mia (TGI) resulting in ‘‘delayed neuronal death” in the CA1
domain of the hippocampus has been widely used to
investigate selective vulnerability (Kirino, 1982; Pulsinelli
et al., 1982). A number of hypotheses have been pro-
posed to explain the mechanisms of cell death, including
continuous neuronal agitation after ischemia (Suzuki
et al., 1983), mitochondrial damage (Abe et al., 1995),
anomalies in Ca2+ homeostasis (Andine et al., 1988),
anomalies in the regulatory mechanisms of glutamate
concentration (Andine et al., 1988), and insuﬃcient pro-
teasome activity (Asai et al., 2002). However, the initial
steps in the cascade leading to cell death are still
unknown because of the limitations of the existing
methodology, strategy, and modalities used.
Lipids, particularly phospholipids, are important for
cellular function due to their structural functions in
cellular membranes and their functions as precursors for
various signaling pathways. Phospholipids, which are
known for their high concentration in the brain, have
important functions both during normal neuronal activity
as well as during pathological processes (Adibhatla
et al., 2006). Neuronal membrane phospholipids are
aﬀected by oxidative stress caused by ischemic injury.
Up to now, there have been numerous studies attempting
to identify key phospholipid components that could show
changes during ischemia and play a critical role for cell
death, to elucidate the mechanism of ischemic vulnerabil-
ity of neuronal cell and to develop eﬀective approach to
prevent brain from ischemic injury (Goto et al., 1988).ons.org/licenses/by-nc-nd/4.0/).
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of hippocampal CA1 has also been suggested (Kubota
et al., 2001). However, because of their diverse and com-
plex structure, there has been more diﬃculty for precise
cellular phospholipid analyses compared with protein or
peptide analyses.
Recently, ‘‘Omics” technology has been used in
combination with conventional methodology to
investigate the early stages of the pathways leading to
cell death (Aebersold and Mann, 2003). Recent technical
innovations in mass spectrometry have been applied to
detect, analyze, and evaluate comprehensive data on
dynamic changes in biological molecules such as proteins
and lipids (Fenn et al., 1989; James et al., 2012). Imaging
mass spectrometry (IMS) is a novel molecular imaging
technique that enables comprehensive analysis of the
spatial intensity distribution proﬁles of molecular species
in biological tissue sections (Cornett et al., 2007; Gessel
et al., 2014; Patterson et al., 2014).
The present study applied IMS to analyze the
molecular kinetics of phospholipids in the hippocampus
after TGI, as IMS analysis is best optimized for these
molecules (Goto-Inoue et al., 2011; Jackson et al.,
2014). The dynamic changes in phospholipids were pro-
ﬁled throughout the apoptotic process from Day 1 after
TGI (the superacute phase) to Day 21 after TGI (the
chronic phase) by correlating the ﬁndings of IMS with con-
ventional histopathological evaluation of adjacent sec-
tions. The aim of this study was to track the initial
features of ischemic neuronal cell death, reﬂected by
changes in phospholipids as important cellular compo-
nents, occurring prior to the morphological change
detected by conventional histopathology. With this work,
we propose new hypotheses to elucidate the mechanisms
of vulnerability of neural cells to ischemic stress via a
comprehensive discovery-based approach instead of the
hypothesis-based approach.EXPERIMENTAL PROCEDURES
Animals
Experiments were performed on male Sprague–Dawley
rats (320–360 g; Charles River, Yokohama, Japan). One
week before the surgery, the animals were housed
under a 12-h light/dark cycle in a climate-controlled
room with food and water available ad libitum. All eﬀorts
were made to minimize the number of animals used and
their suﬀering. All experimental procedures were
performed in accordance with the Animal Use
Guidelines of The University of Tokyo, and approved by
the Animal Care and Use Committee of The University
of Tokyo (approved number P13-007) and Hamamatsu
University School of Medicine.Surgical procedure for global ischemia
The procedure for the induction of global ischemia in rats
was reported previously (Kawahara et al., 2004). Brieﬂy,
12 h before the induction of ischemia, each rat was anes-
thetized with 2.0% halothane in a mixture of 30% O2 and
70% N2 and the head secured in a stereotactic frame.Under the operating microscope, the ﬁrst vertebral foram-
ina were drilled through to locate the vertebral arteries
which were exposed bilaterally, coagulated, and cut com-
pletely. The animals were then fasted overnight. After
12 h, the animals were anesthetized with 4% halothane
in a mixture of 30% O2 and 70% N2, intubated and main-
tained under mechanical ventilation (2.0 mL 100 cycles/
min, 1.5% isoﬂurane in a mixture of 30% O2 and 70%
N2O). The partial pressures of arterial O2 and CO2 were
maintained within the normal ranges throughout the sur-
gery, and the rectal and temporal temperatures were
maintained at 37.5 ± 0.2 C with a heating pad and a
heat lamp, respectively. Cerebral ischemia was induced
for 6 min by occluding both common carotid arteries with
aneurysm clips. The reproducibility of the global ischemia
was further ensured by maintaining the mean blood pres-
sure at 50 mmHg during occlusion by withdrawing blood
from the right femoral artery and monitoring the blood
pressure through a cannula in the left femoral artery.
The clips were then removed to restore cerebral blood
ﬂow and anesthesia withdrawn. After regaining sponta-
neous respiration, the rats were extubated and returned
to their cages. Sham control rats were treated similarly,
except for the vertebral artery coagulation and carotid
artery clipping procedures.Preparation of tissue samples
The rats were euthanized on Days 1, 2, 4, 7, 10, 14, and
21 (n= 3 per time point) under 4% deep halothane
anesthesia and then decapitated. The brains were
rapidly removed, frozen in powdered dry ice, and stored
at 80 C. Coronal cryostat sections (10 lm) containing
the hippocampus at the level of approximately 3.3 mm
caudal from the bregma were placed onto normal glass
slides and stored at 80 C for immunohistochemistry,
or placed onto glass slides coated with indium tin oxide
(Bruker Daltonics, Bremen, Germany) and stored at
20 C until matrix application and subsequent IMS
analysis.Immunohistochemistry
Rat brain sections on ordinary glass slides were warmed
to room temperature (RT) and then air dried with a dryer
for 20 min. After circling with a PAP pen, the sections
were ﬁxed with 4% paraformaldehyde/phosphate-buﬀered
saline for 20 min at RT. The sections were stained with
hematoxylin–eosin or cresyl violet, or immunostained for
other markers. For immunohistochemical studies, the
sections were rinsed well three times in Tris-buﬀered
saline with 0.5% Tween (TBS/T) for 3 min. After blocking
with 5% normal donkey serum in TBS/T at RT for 1 h,
the sections were incubated overnight at 4 C with the
following primary antibodies: anti-neuronal nuclei (NeuN)
antibody (1:500; Chemicon Mouse IgG MAB377,
Millipore Corporation, Billerica, MA, USA) for neuronal
cells, anti-ectodermal dysplasia 1 (ED1) antibody (1:300;
AbD Setotec Mouse IgG MCA341R, Raleigh, NC, USA)
for activated microglia, and anti-glial ﬁbrillary acidic
protein (GFAP) antibody (1:2000; Abcam Rabbit IgG
7260, Cambridge, United Kingdom) for activated
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and incubated for 1 h at RT with appropriate secondary
antibodies conjugated with Alexa 488, 546 (1:200;
Molecular Probes, Eugene, OR, USA) for
immunoﬂuorescent staining for NeuN and GFAP, or with
an appropriate biotinylated secondary antibody for the avi
din–biotin–peroxidase complex method and
diaminobenzidine detection for ED1. The numbers of
NeuN-positive cells, GFAP-positive cells, and ED1-
positive cells were counted in microscopic ﬁelds for an
area of 500  750 lm (0.375 mm2) in the hippocampal
CA1 domain, covering the stratum radiatum, pyramidal
cell layer, and stratum oriens. Three coronal sections per
animal at levels approximately 2.8/3.3/3.8 mm caudal
from the bregma were collected and averaged.
IMS analysis
Rat brain sections on indium tin oxide-coated glass slides
were attached to a special holder and inserted into a
mass microscope (Shimadzu, Kyoto, Japan). The mass
spectrometer is equipped with a matrix-assisted laser
desorption/ionization (MALDI) chamber, a quadrupole
ion trap, and a time of ﬂight instrument. The objective
lens enables observation of the sample in the MALDI
chamber at high resolution (magniﬁcation: 1.25, 2.5,
5, 10, 20, and 40; Olympus, Tokyo, Japan). After
obtaining an optical image and determining the
measurement area for IMS analysis, the special holder
was ejected from the mass microscope to coat the 2,5-
dihydroxybenzoic acid matrix. A thin matrix layer was
homogeneously applied onto the surface with a matrix
sublimation instrument (Shimadzu) according to the
following steps described later. Approximately 200 mg of
2,5-dihydroxybenzoic acid was placed in a tungsten
boat at the bottom of the instrument chamber. The
chamber was evacuated to a pressure of 10–20 Pa, and
the tungsten boat was heated to 170 C for 3 min. The
special holder was then re-inserted into the mass
microscope. IMS analysis was performed with a Nd/
YAG laser running at 400 Hz, and mass spectra were
obtained from 80 laser shots per measurement point in
the range of m/z 700–900 in positive-ion mode. The
spatial resolution (raster-scan pitch) was 15 lm per
pixel. Laser energy was optimized to maximize the
sensitivity of the signal detection in IMS analysis. The
IMS dataset acquired by the mass microscope was
converted to the ANALYZE 7.5 format ﬁle using special
converter software (Shimadzu). The IMS data were
statistically analyzed with SIMtool software (Shimadzu).
Signal intensity was represented for each
phosphatidylcholine (PC) species as relative intensity to
the internal control in each slice. PC (diacyl-18:0/18:1)
was used as the internal control, which was most
abundant in corpus callosum and showed no
histopathological changes through the time course after
ischemia in our model (Kawahara et al., 2004). The abun-
dance of PC (diacyl-18:0/18:1) in the corpus callosum
was reported in a previous study (Sugiura et al., 2009).
The signal intensity of each PC species was used to
assess the correlation to the histopathological cell
counts at a next stage.Abbreviations for glycerophospholipids
The structures of the side chains of glycerophospholipid
species with one or two radial side chains are indicated
within parentheses in the ‘‘head group (coupling
scheme-sn1/sn2)” format [e.g., PC (diacyl-16:0/18:1)].
Statistical analysis
All data are expressed as mean ± standard deviation.
Statistical analysis was conducted by a one-way
analysis of variance for the cell count and relative
intensity of the mass spectrum for comparing more than
two groups, followed by the post hoc Bonferroni–Dunn
test. Student’s t-test was used for comparing two
groups. Spearman’s Rank Correlation test was applied
to evaluate the correlation between PC signal intensity
and histopathological cell count across all sampled
experimental animals. Diﬀerences were considered
signiﬁcant at P< 0.05.
RESULTS
HistopathologyHematoxylin–eosin and cresyl violet staining. Normal
morphological features with intact, round neuronal cell
bodies were found in the pyramidal cell layers of the
hippocampus and dentate gyrus in the sham controls.
Similarly, no morphological abnormality was found in the
hippocampal pyramidal cells and dentate gyrus of rats
sacriﬁced on Day 1 after global ischemia (Fig. 1). This
phase from the onset of ischemia to the end of Day 1 is
called the superacute phase in this study. Abnormal
morphological features were observed in some
pyramidal neurons in the hippocampal CA1 on Day 2
after ischemia: shrinkage and triangulation of nucleus
and cytoplasm, and increased eosinophilia of cytoplasm
(data not shown). These characteristic features of
ischemic damage became more apparent on Day 4
(data not shown). Degenerative morphological changes,
characteristic of cell death, were observed in most
pyramidal cells of the hippocampal CA1 on Day 7. This
phase from Days 2 to 7 was called the subacute phase
in this study. Next the pyramidal cells of the
hippocampal CA1 had been replaced by numerous cells
of unknown origin, morphologically resembling
inﬂammatory cells, by Day 21. This phase was called
the chronic phase in this study.
ImmunohistochemistryNeuN-immunoreactive neurons. The numbers of
NeuN-immunoreactive cells in the pyramidal cell layer in
the hippocampus and dentate gyrus were approximately
the same in both the sham controls and the
experimental rats on Day 1 after ischemia (Fig. 2A). The
numbers of NeuN-immunoreactive cells began to
decline gradually on Day 2 (data not shown), and most
NeuN-immunoreactive cells in the hippocampal CA1
disappeared by Day 7 in the subacute phase.
Fig. 1. Hematoxylin–eosin (HE) and cresyl violet staining of the rat hippocampus after transient global ischemia (TGI). In the sham controls, the
pyramidal neuronal cells in the hippocampus and dentate gyrus had normal morphological features with intact, round neuronal cell bodies. On Day 1
after TGI (superacute phase), the hippocampal pyramidal cells and dentate gyrus had no morphological abnormalities, similar to the sham controls.
On Day 7 (subacute phase), most pyramidal cells of the hippocampal CA1 showed degenerated morphological changes of cell death. On Day 21
(chronic phase), the pyramidal cells of hippocampal CA1 were replaced by numerous cells of unknown origin, morphologically resembling
inﬂammatory cells.
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Day 21 in the chronic phase. The number of
NeuN-immunoreactive cells in the hippocampal CA1
was similar in the superacute phase and in the sham
controls (164.0± 25.0 vs 166.6 ± 16.0 cells/0.375 mm2),
but decreased signiﬁcantly in the subacute phase
compared to the sham controls (29.6 ± 10.3 vs 166.6
± 16.0 cells/0.375 mm2, P< 0.001), and decreased
even more signiﬁcantly in the chronic phase (5.6 ± 2.1
vs 166.6 ± 16.0 cells/0.375 mm2, P< 0.001) (Fig. 2C).
These results conﬁrmed that the delayed neuronal cell
death observed by conventional histopathology had
begun in the subacute phase.GFAP-immunoreactive astrocytes. GFAP-immuno-
reactive astrocytes maintained normal shapes with thin
long processes in both sham control and superacute
phase specimens (Fig. 2A). Apparent morphological
changes appeared in the hippocampal CA1 in the
subacute phase, such as typical hypertrophic astrocytes
with thickened processes and enlarged cell bodies.
The number of hypertrophic GFAP-immunoreactive
astrocytes increased and gliosis progressed together
with fewer NeuN-immunoreactive cells in the chronic
phase. This number, however, was similar in the
superacute phase and in the sham controls (192.3 ± 13.6
vs 201.6 ± 6.0 cells/0.375 mm2) (Fig. 2D). The number
of GFAP-immunoreactive cells increased signiﬁcantly
compared to the sham controls at later time points
(Day 7) (255.3 ± 24.6 vs 201.6 ± 6.0 cells/0.375 mm2,
P< 0.001), and remained signiﬁcantly higher in the
chronic phase (273.3±18.5 vs 201.6± 6.0 cells/0.375mm2,P< 0.001). These results showed that no morpho-
logical change occurred in the astrocytes in the
superacute phase, but gliosis with hypertrophic GFAP-
immunoreactive astrocytes became dominant in the
hippocampal CA1 in the subacute phase and persisted
until the chronic phase.
ED1-immunoreactive microglia. No ED1-immuno-
reactive microglia was observed in the hippocampal
CA1 or dentate gyrus in the sham controls or in the
superacute phase (Fig. 2B). ED1-immunoreactive
microglial cells began to emerge on Day 2 (data not
shown), and their number increased signiﬁcantly on
Day 7 predominantly in the pyramidal cell layer of the
hippocampal CA1. ED1-immunoreactive microglia widely
spread across the hippocampal CA1 in the chronic
phase. ED1-immunoreactive cells were undetected in
the hippocampal CA1 in the superacute phase and in
the sham controls, but the number of cells increased
signiﬁcantly in the subacute phase compared to the
sham controls (255.0 ± 22.9 vs 0 cells/0.375 mm2,
P< 0.001), and remained signiﬁcantly higher in the
chronic phase (232.6 ± 20.8 vs 0 cells/0.375 mm2,
P< 0.001) (Fig. 2E). These results conﬁrmed that
ED1-immunoreactive cells were absent in the superacute
phase, dramatically proliferated in the subacute phase,
and persisted until the chronic phase.
IMS analysisProfiling of sham control hippocampus. The MALDI-
IMS system was used in the positive ion detection mode
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the hippocampus during the course of delayed neuronal
cell death (from the superacute to the chronic phase).
Approximately 150 peaks were detected in the mass
range of 700 <m/z< 900 (Fig. 3A). Ten intense mass
peaks were assigned to abundant PC species based on
their molecular masses and previously reported data
(Sugiura et al., 2009; Koizumi et al., 2010; Hanada
et al., 2012), and the tissue distributions of these 10 major
species in the hippocampus were visualized (Fig. 3B).
IMS analysis of the hippocampus of the sham controls
revealed characteristic PC distribution patterns depen-
dent on fatty acid composition, which reﬂected the hetero-geneous membrane lipid compositions of distinct cell
types. For example, PC (diacyl-16:0/20:4) was evenly dis-
tributed across the entire hippocampus and dentate
gyrus. On the other hand, PC (diacyl-16:0/18:1), which
is the most abundant molecule in the hippocampus, and
PC (diacyl-16:0/16:0) were also distributed across the
entire hippocampus and dentate gyrus but were less dom-
inant in the pyramidal cell layer of the hippocampus and
granular cell layer of the dentate gyrus. PC (diacyl-
18:0/18:1) was mainly distributed in the white matter,
such as the corpus callosum, and less dominant in the
hippocampus and gray matter. These results conﬁrmed
that IMS had adequate sensitivity to discriminate the
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their molecular masses.Profiling of the hippocampus in the superacute phase.
No histological changes were observed in the superacute
phase after TGI, but IMS showed increases in three PC
species in the pyramidal cell layer: PC (diacyl-
16:0/20:4), PC (diacyl-16:0/22:6), and PC (diacyl-
18:0/20:4) (Fig. 4A). On the other hand, no changes
were observed in three other PC species: PC (diacyl-
16:0/16:0), PC (diacyl-18:0/18:1), and PC (diacyl-
16:0/16:1) (Fig. 5). The PC species showing increases
contained polyunsaturated fatty acids, such as
docosahexaenoic acid (DHA) (22:6) and arachidonic
acid (AA) (20:4) (Fig. 4A). The PC species which
contained AA (20:4), PC (diacyl-16:0/20:4), and PC
(diacyl-18:0/22:4) increased in the pyramidal cell layer of
the hippocampal CA1, the pyramidal cell layer of the
hippocampal CA3, and the granular cell layer of the
dentate gyrus. In particular, PC (diacyl-16:0/22:6) was
the only species to show a signiﬁcantly greater increase
speciﬁcally in the pyramidal cell layer of CA1. Semi-
quantitative measurements showed that the signal
intensity ratio of PC (diacyl-16:0/22:6) in the pyramidal
cell layer of the CA1 was signiﬁcantly higher in the
superacute phase than in the sham controls (0.91
± 0.05 vs 0.61 ± 0.02, P< 0.001) (Fig. 4B). These
ﬁndings, together with the absence of morphological
change, indicate that the changes in PC species reﬂect
remodeling of the cell components rather than cell
replacement.Profiling of the hippocampus in the subacute phase.
The histopathological study showed reduction of
pyramidal cells in the hippocampal CA1 and
replacement by ED1-immunoreactive microglial cells
and gliosis (higher number of hypertrophic GFAP-
immunoreactive astrocytes). In this cellular environment,
only one PC species, PC (diacyl-16:0/18:1), speciﬁcally
increased in that domain (Fig. 6A). The signal intensity
ratio of PC (diacyl-16:0/18:1) in the hippocampal CA13
Fig. 2. Immunohistochemical analyses of the rat hippocampus after transien
(GFAP) and neuronal nuclei (NeuN). In the sham controls, the pyramidal cell
immunoreactivity. GFAP-immunoreactive astrocytes had normal shapes, wit
approximately the same numbers of NeuN-immunoreactive cells were p
maintained normal shapes, with thin long processes. On Day 7 (subacu
disappeared. Apparent morphological changes had emerged in GFAP-im
hypertrophic astrocytes with thickened processes and enlarged cell bodies.
completely disappeared. The number of hypertrophic GFAP-immunoreactive a
1 (ED1) staining with hematoxylin staining. No ED1-immunoreactive microglia
controls and in the superacute phase. On Day 7 (subacute phase), the numb
predominantly accumulated in the pyramidal cell layer of the hippocampal C
distributed widely across the hippocampal CA1. (C) The number of NeuN
superacute phase (n= 3) and in the sham controls (n= 3) (164.0 ± 25.0 vs
subacute phase (n= 3) (29.6 ± 10.3 vs 166.6 ± 16.0 cells/0.375 mm2, *P
controls (n= 3) (5.6 ± 2.1 vs 166.6 ± 16.0 cells/0.375 mm2, *P< 0.001).
superacute phase (n= 3) and in the sham controls (n= 3) (192.3 ± 13.6 vs
7 (n= 3) compared to the sham controls (n= 3) (255.3 ± 24.6 vs 201.6 ±
the chronic phase (n= 3) (273.3 ± 18.5 vs 201.6 ± 6.0 cells/0.375 mm2,
hippocampal CA1 in the superacute phase and in the sham controls. The
subacute phase (n= 3) compared to the sham controls (n= 3) (255.0 ± 22.
in the chronic phase (n= 3) (232.6 ± 20.8 vs 0 cells/0.375 mm2, *P< 0.00was signiﬁcantly higher in the subacute phase than in
the sham controls (3.03 ± 0.16 vs 1.87 ± 0.12,
*P< 0.001) (Fig. 6B). In contrast, three PC species, PC
(diacyl-16:0/16:0), PC (diacyl-18:0/18:1), and PC (diacyl-
16:0/16:1), showed no apparent changes in the
subacute phase (Fig. 5). On the other hand, three PC
species, PC (diacyl-16:0/20:4), PC (diacyl-16:0/22:6),
and PC (diacyl-18:0/20:4), showed transient increase in
the superacute phase and decrease to baseline level in
the subacute phase (Fig. 4). These results indicate that
the increase of PC (diacyl-16:0/18:1) in the hippocampal
CA1 can be attributed to cellular replacement by
microglia and hypertrophic astrocytes in the subacute
phase (Fig. 2).Profiling of hippocampus in the chronic phase. The
histopathological study showed total loss of neuronal
cells in the hippocampal CA1 and accumulation of ED1-
immunoreactive microglial cells together with progress
of gliosis (higher number of hypertrophic GFAP-
immunoreactive astrocytes) in the chronic phase
(Fig. 2). These ﬁndings indicate that replacement of
neuronal cells in the hippocampal CA1 by other types of
cells had begun in the subacute phase and was almost
complete in the chronic phase (Fig. 2). PC (diacyl-
16:0/18:1) signiﬁcantly increased in the CA1 in this
phase (Fig. 6A). On the other hand, three PC species,
PC (diacyl-16:0/16:0), PC (diacyl-18:0/18:1), and PC
(diacyl-16:0/16:1), showed no change as in the previous
superacute and subacute phase (Fig. 5). The three PC
species, PC (diacyl-16:0/20:4), PC (diacyl-16:0/22:6),
and PC (diacyl-18:0/20:4), which showed transient
increase in the superacute phase and decrease to
baseline level in the subacute phase, also remained at
the baseline in the chronic phase (Fig. 4A). The signal
intensity ratio of PC (diacyl-16:0/18:1) in the
hippocampal CA1 was signiﬁcantly higher in the chronic
phase than in the sham controls (3.23 ± 0.27 vs 1.87
± 0.12, *P< 0.001) (Fig. 6B). These results indicate
that increase of PC (diacyl-16:0/18:1) in CA1
reﬂects the replacement of neuronal cells byt global ischemia. (A) Double staining with glial ﬁbrillary acidic protein
layer in the hippocampus and dentate gyrus apparently showed NeuN
h thin long processes. On Day 1 after ischemia (superacute phase),
resent as in the sham controls. GFAP-immunoreactive astrocytes
te phase), most NeuN-positive cells of the hippocampal CA1 had
munoreactive astrocytes in the hippocampal CA1, such as typical
On Day 21 (chronic phase), NeuN-immunoreactive cells had almost
strocytes increased and gliosis progressed. (B) Ectodermal dysplasia
was observed in the hippocampal CA1 or dentate gyrus in the sham
er of ED1-immunoreactive microglial cells increased signiﬁcantly and
A1. In the chronic phase, ED1-immunoreactive microglial cells were
-immunoreactive cells in the hippocampal CA1 was similar in the
166.6 ± 16.0 cells/0.375 mm2), but had signiﬁcantly decreased in the
< 0.001) and in the chronic phase (n= 3) compared to the sham
(D) The number of GFAP-immunoreactive cells was similar in the
201.6 ± 6.0 cells/0.375 mm2), but had signiﬁcantly increased on Day
6.0 cells/0.375 mm2, *P< 0.001) and remained signiﬁcantly higher in
*P< 0.001). (E) ED1-immunoreactive cells were undetected in the
number of ED1-immunoreactive cells increased signiﬁcantly in the
9 vs 0 cells/0.375 mm2, *P< 0.001), and remained signiﬁcantly higher
1). N.S., not signiﬁcant.
Fig. 3. (A) Representative matrix-assisted laser desorption/ionization mass spectrometry spectrum obtained from the rat hippocampal CA1 of the
sham control. Intense mass peaks corresponding to 10 abundant phosphatidylcholines (PCs) were assigned based on their masses and previously
reported data. (B) Diﬀerential distribution of PC species in the hippocampus of the sham controls. Imaging mass spectrometry (IMS) images of PCs
are arranged according to their fatty acid (FA) compositions; PCs with identical FA compositions at the sn-1 position are arranged vertically, and
PCs with identical FA compositions at the sn-2 position are arranged horizontally. The speciﬁc FA composition is associated with several unique
localization features in the hippocampus. IMS analysis of the sham controls revealed characteristic PC distribution patterns dependent on FA
composition, which reﬂected the heterogeneous membrane lipid compositions of distinct cell types. For example, PC (diacyl-16:0/20:4) was
distributed across the entire hippocampus and dentate gyrus. On the other hand, PC (diacyl-16:0/18:1), which is the most abundant molecule in the
hippocampus, and PC (diacyl-16:0/16:0) were also distributed across the entire hippocampus and dentate gyrus but were less dominant in the
pyramidal cell layer of the hippocampus and granule cell layer of the dentate gyrus. PC (diacyl-18:0/18:1) was mainly distributed in the white matter,
such as the corpus callosum, and less dominant in the hippocampus or gray matter. (C) Scheme of the rat brain section including the hippocampus.
Scheme shows CA1 lesion, CA3 and dentate gyrus (DG) of the hippocampus and corpus callosum (CC). Scheme was quoted from ‘‘The rat brain in
stereotaxic coordinates (6th edition)” (Paxinos and Watson, 2006) and partially modiﬁed with the permission of ELSEVIER.
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Fig. 4. (A) Imaging mass spectrometry analysis of phosphatidylcholine (PC) species which increased in the hippocampal CA1 in the superacute
phase. Three PC species, PC (diacyl-16:0/20:4), PC (diacyl-16:0/22:6), and PC (diacyl-18:0/20:4), increased in the pyramidal cell layer during the
superacute phase (arrowheads), when no histological changes had occurred (n= 3). These PC species contained polyunsaturated fatty acid, such
as docosahexaenoic acid (22:6) and arachidonic acid (20:4). PC species which contained arachidonic acid (20:4), PC (diacyl-16:0/20:4), and PC
(diacyl-18:0/20:4) increased in the pyramidal cell layer of the hippocampal CA1, the pyramidal cell layer of the hippocampal CA3, and the granule
cell layer of the dentate gyrus. PC (diacyl-16:0/22:6) was the only species to show a signiﬁcantly greater increase speciﬁcally in the pyramidal cell
layer of the hippocampal CA1 (n= 3). (B) The signal intensity ratio of PC (diacyl-16:0/22:6) in the pyramidal cell layer of the hippocampal CA1 was
signiﬁcantly higher in the superacute phase (n= 3) than in the sham controls (n= 3) (0.91 ± 0.05 vs 0.61 ± 0.02, *P< 0.001). However, the
signal intensity ratio of PC (diacyl-16:0/22:6) in the pyramidal cell layer of the hippocampal CA1 in the subacute phase (n= 3) did not show
signiﬁcant diﬀerence compared to sham controls (n= 3) (0.59 ± 0.02 vs 0.61 ± 0.02) nor that in the chronic phase (n= 3) (0.60 ± 0.05 vs 0.61
± 0.02).
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GFAP-immunoreactive astrocytes in the chronic phase.Correlation analysis between PC (diacyl-16:0/18:1)
and cell count of GFAP-immunoreactive astrocyte
The signal intensity of PC (diacyl-16:0/18:1) and the cell
count of GFAP-immunoreactive astrocyte had signiﬁcantcorrelation (Spearman rank correlation coeﬃcient
r= 0.85, p< 0.05).
DISCUSSION
The present study used the TGI model to compare the
molecular and histological features of delayed neuronal
cell death. The TGI model rather than a focal ischemia
model was used because the process of cell death after
Fig. 5. Imaging mass spectrometry analysis of phosphatidylcholine (PC) species that showed no apparent change in the time course after transient
global ischemia. Three PC species, PC (diacyl-16:0/16:0), PC (diacyl-18:0/18:1), and PC (diacyl-16:0/16:1), showed no apparent change in the
superacute (n= 3), subacute (n= 3), or chronic phases (n= 3).
Fig. 6. (A) Imaging mass spectrometry analysis of phosphatidylcholine (PC) species showed increase in the hippocampal CA1 in the subacute
phase and chronic phase. One PC species, PC (diacyl-16:0/18:1), increased in the hippocampal CA1 speciﬁcally in the subacute (n= 3) and
chronic phases (n= 3). (B) The signal intensity ratio of PC (diacyl-16:0/18:1) in the hippocampal CA1 in the superacute phase (n= 3) did not show
signiﬁcant changes compared to that in sham controls (n= 3) (1.82 ± 0.18 vs 1.87 ± 0.12). However, the signal intensity ratio of PC (diacyl-16:0/
18:1) in the hippocampal CA1 was signiﬁcantly higher in the subacute phase than in the sham controls (3.03 ± 0.16 vs 1.87 ± 0.12, *P< 0.001)
and in the chronic phase (3.23 ± 0.27 vs 1.87 ± 0.12, *P< 0.001).
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S. Miyawaki et al. / Neuroscience 322 (2016) 66–77 75focal ischemia (mainly necrosis) occurs within minutes
compared to the slow progress of delayed neuronal cell
death over days after global ischemia. Therefore, only
the global ischemia model provides suﬃcient time for
detailed IMS analysis (Kirino, 1982; Pulsinelli et al.,
1982). The region of interest was limited to the hippocam-
pal CA1 cell layer because this anatomical region is most
vulnerable to ischemia and undergoes cell death with high
reproducibility. Such reproducibility is critical, because
IMS analysis focuses on morphologically intact cells
which will ﬁnally undergo cell death. The animal model
of TGI was developed by Kirino (1982), who discovered
the phenomenon of delayed neuronal cell death in the
gerbil. Since then, the gerbil forebrain ischemia model
has been developed for research on delayed neuronal cell
death, and various experimental studies have advanced
our knowledge on stroke (Kawahara et al., 1998; Asai
et al., 2002; Yonekura et al., 2006). Adding induced
hypotension to 4-vessel occlusion in the rat model has fur-
ther enhanced reproducibility, allowing the investigation of
gene expression during the superacute phase of ischemia
directly after global cerebral ischemia (Kawahara et al.,
2004), as well as neuronal cell regeneration induced by
activation of endogenous stem cells by administering
growth factors to tissues after ischemic neuronal cell
death (Nakatomi et al., 2002; Kawahara et al., 2004;
Oya et al., 2009).
The present study extended from Days 1 to 21 after
TGI. Thus, we could evaluate the molecular changes
not only in the superacute phase after TGI but also in
the subacute to chronic phases. The histopathological
ﬁndings showed that activated microglial cells and
reactive astrocytes replaced the neurons of the
hippocampal CA1 during these last two phases. This
period provided the most suitable conditions for IMS
investigation since the apparent morphological changes
should be reﬂected in the proﬁle of the PC species due
to the replacement of cells. Previous IMS ﬁndings using
this ischemia model have revealed the molecular
changes associated with tissue replacement in the
chronic phase after ischemia (Koizumi et al., 2010;
Hankin et al., 2011; Shanta et al., 2012; Wang et al.,
2012). In the present study, IMS revealed that PC
(diacyl-16:0/18:1) increased throughout the whole CA1
domain after TGI (Fig. 6). PC (diacyl-16:0/18:1) is a type
of phospholipid which contains oleic acid (18:1), a
monounsaturated fatty acid. Monounsaturated fatty acids
have been reported to increase in reactive astrocytes,
indicating the important role of monounsaturated fatty
acid in gliotic change in the brain (Glynn, 2013). More-
over, monounsaturated fatty acids, including oleic acid
(18:1), have been related to microglial activation (Button
et al., 2014). These observations could be an explanation
for our ﬁnding of increase in PC species including oleic
acid (18:1) in hippocampal CA1 in the subacute to the
chronic phases after TGI, where activated microglial cells
and reactive astrocytes replaced the neurons. Therefore,
PC (diacyl-16:0/18:1) is an important component and
might be a biomarker of inﬂammatory change in the hip-
pocampus. The signiﬁcant correlation between the signal
intensity of PC (diacyl-16:0/18:1) and the cell count ofGFAP immunoreactive astrocytes supports our specula-
tion about the association between PC (diacyl-
16:0/18:1) and gliosis.
In this study, histopathology revealed no apparent
morphological change in the hippocampal CA1 during
the superacute phase (Day 1 after ischemia). However,
the neuronal cells of the hippocampal CA1 are clearly
destined to undergo cell death at this time point, as the
CA1 neuronal cells should start remodeling from their
normal state toward neuronal cell death after exposure
to ischemia. Therefore, we suggest that detection of
molecular changes in neuronal cells in the remodeling
phase, or immediately after global cerebral ischemia, is
equivalent to detecting the initiation of the molecular
changes associated with programed neuronal cell death
or apoptosis. In this study, IMS could detect the types of
changes occurring in the remodeling phase at the level
of metabolic molecules, which would not be possible by
other modalities due to limitations in sensitivity.
The present study revealed that speciﬁc increase of
PC (diacyl-16:0/22:6) occurs in the pyramidal cell layer
of the hippocampal CA1 on Day 1 after ischemia
(Fig. 4). Association of PC (diacyl-16:0/22:6) and
foreplay processes involved in cell death is speculated
by the fact that PC (diacyl-16:0/22:6) was the only PC
species increased in the pyramidal cell layer of
the hippocampal CA1 on Day 1 after ischemia. The
absence of histopathological changes in the
hippocampal CA1 on Day 1 after ischemia precluded
the possibility of correlation analysis of signal intensity
of PC (diacyl-16:0/22:6) and any quantitative cell
changes in that area of interest.
There are several reports showing increase and
decrease of speciﬁc phospholipids in the brain in
neurodegenerative diseases, such as Alzheimer’s
disease, as a result of membrane degradation (Grimm
et al., 2011). We believe that the increase of PC (diacyl-
16:0/22:6) in the pyramidal cell layer of the hippocampal
CA1 should be a result of membrane degradation conse-
quent to ischemic stress.
Such increase in PC (diacyl-16:0/22:6) in the
hippocampal CA1 might occur through several
molecular mechanisms. For example, the compositional
diversity of PCs is tightly regulated to maintain
homeostasis under physiological conditions
(Hermansson et al., 2011). The balance between synthe-
sis and degradation is controlled by various enzymes,
such as phospholipase A2 and lysophospholipid acyl-
transferases (Sun et al., 2004; Shindou and Shimizu,
2009). Under pathological conditions, such as ischemia,
the activities of these enzymes might change resulting
in loss of physiological balance. Consequently, the
increase of PC (diacyl-16:0/22:6) emerged, presumably
due to the increase of synthesis or decrease of degrada-
tion of PC (diacyl-16:0/22:6).
The present ﬁndings indicate that increased levels of
PC (diacyl-16:0/22:6) could be a biomarker for neuronal
cells of hippocampus CA1 destined to progress to
apoptosis, although its exact biochemical role for
neuronal cell death is still unknown. One possibility is
that the increase of PC (diacyl-16:0/22:6) results from
76 S. Miyawaki et al. / Neuroscience 322 (2016) 66–77the decreased degradation of PC (diacyl-16:0/22:6). PC
(diacyl-16:0/22:6) is known to contain DHA, a type of
polyunsaturated fatty acid, which is freed from PC by
phospholipase A2 and metabolized to provide various
mediators with neuroprotective function (Serhan et al.,
2006; Eady et al., 2012). Decreased degradation of PC
(diacyl-16:0/22:6) might decrease the relative amount of
DHA and its anti-apoptotic eﬀect in the neuronal cell
and consequently contribute to delayed neuronal cell
death. To prove this hypothesis, further molecular biolog-
ical analysis is required, such as identiﬁcation of the
speciﬁc degradation enzyme of PC (diacyl-16:0/22:6) with
function inhibited under ischemic stress.
While we focused on dynamics of PC species in
neuronal cell death in this study, the brain lipidome is
quite diverse, consisting of glycerophospholipids such
as phosphatidylethanolamines, phosphatidylinositols,
phosphatidylserine, phosphatidylglycerols, cardiolipins,
and glycerolipids, mainly triacylglycerols, besides PCs.
Therefore we have to admit the possibility that other
lipid species besides PC species may show signiﬁcant
changes in the superacute phase of TGI. Visualization
of diverse lipid species by IMS would be enabled using
appropriate matrix, such as ionized silver particles
(Jackson et al., 2014). Coupling of IMS with MALDI-ion
mobility mass spectrometry would be also a robust
method to allow the separation and detection of a wide
range of diverse lipid species (Jackson et al., 2014).
There have been several reports emphasizing the
importance that a well-deﬁned sample handling
procedure can minimize the time-dependent lipid
degradation of the samples prepared for IMS analysis
(Patterson et al., 2014; Thomas and Chaurand, 2014).
According to the procedure, rat brains were rapidly
removed from the skull within a few minutes after euthana-
sia and frozen in powdered dry ice, and then stored at
80 C until use. The coronal cryostat sections placed
onto glass slides were applied with matrix and subsequent
IMS analysis was performed. As the present study dealt
with extremely subtle molecular changes associated with
TGI, we have paid special attention to minimize such post-
mortem changes and the time-dependent degradation of
PCs in the samples. Then, the protocol applied in the study
is likely to provide a state close to the condition of in situ to
detect the molecular changes speciﬁc with TGI.
The present study demonstrated that IMS can detect
subtle molecular changes such as increase of PC
(diacyl-16:0/22:6) in the cells of tissue slices while
maintaining the neuroanatomical information, so is a
powerful method for studying the molecular mechanisms
associated with delayed cell death. The applicability and
usefulness of IMS for biological research has been
increasingly recognized in several diﬀerent areas (Waki
et al., 2014; Yuki et al., 2014). Further development of
IMS, such as higher resolution imaging and technical
improvement to detect molecules in smaller quantities
(Van de Plas et al., 2015; Waki et al., 2015), will allow
detection of a wider range of proteins in addition to phos-
pholipids which have important biological functions.
Therefore IMS has the potential to achieve further pro-
gress in the study of ischemia.SOURCES OF FUNDING
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